Reuters logo
BRIEF-Celsion presents two posters on its GEN-1 IL-12 gene-mediated immunotherapy
February 27, 2017 / 1:47 PM / 7 months ago

BRIEF-Celsion presents two posters on its GEN-1 IL-12 gene-mediated immunotherapy

Feb 27 (Reuters) - Celsion Corp

* Celsion presents two posters on its GEN-1 IL-12 gene-mediated immunotherapy at the ASCO-SITC clinical immuno-oncology symposium

* Celsion Corp - in first twelve patients dosed in ovation study, GEN-1 plus standard chemotherapy produced impressive clinical results

* Celsion Corp - Celsion expects to complete enrollment and treatment phase of ovation study early in Q2

* Celsion - expects to report final data from ovation study , including translational data for all patients, by end of Q2 of 2017 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below